Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 09-2003 | 06-2003 | 03-2003 | 12-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,190 | -1,400 | -2,060 | -1,590 | -1,070 |
| Depreciation Amortization | 10 | 8 | 30 | 30 | 10 |
| Other Working Capital | 230 | 110 | -110 | 10 | -110 |
| Other Operating Activity | 1,090 | 852 | 140 | 140 | 130 |
| Operating Cash Flow | $-860 | $-430 | $-2,000 | $-1,410 | $-1,040 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | 0 | -30 | -110 | -2 |
| Other Investing Activity | 632 | 390 | 1,530 | 780 | 672 |
| Investing Cash Flow | $630 | $390 | $1,500 | $670 | $670 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 190 | 0 | 20 | 20 | 10 |
| Financing Cash Flow | $190 | $0 | $20 | $20 | $10 |
| Beginning Cash Position | 320 | 320 | 790 | 790 | 790 |
| End Cash Position | 280 | 270 | 320 | 70 | 430 |
| Net Cash Flow | $-30 | $-40 | $-470 | $-720 | $-360 |
| Free Cash Flow | |||||
| Operating Cash Flow | -860 | -430 | -2,000 | -1,410 | -1,040 |
| Free Cash Flow | -860 | -430 | -2,000 | -1,410 | -1,040 |